Repurposing Ponatinib as a Potent Agent against KIT Mutant Melanomas.
Han Y, Gu Z, Wu J, Huang X, Zhou R, Shi C, Tao W, Wang L, Wang Y, Zhou G, Li J, Zhang Z, Sun S.
Han Y, et al.
Theranostics. 2019 Mar 16;9(7):1952-1964. doi: 10.7150/thno.30890. eCollection 2019.
Theranostics. 2019.
PMID: 31037149
Free PMC article.